Cargando…
Digital Quantification of Gene Expression in Sequential Breast Cancer Biopsies Reveals Activation of an Immune Response
Advancements in molecular biology have unveiled multiple breast cancer promoting pathways and potential therapeutic targets. Large randomized clinical trials remain the ultimate means of validating therapeutic efficacy, but they require large cohorts of patients and are lengthy and costly. A useful...
Autores principales: | Jeselsohn, Rinath M., Werner, Lillian, Regan, Meredith M., Fatima, Aquila, Gilmore, Lauren, Collins, Laura C., Beck, Andrew H., Bailey, Shannon T., He, Housheng Hansen, Buchwalter, Gilles, Brown, Myles, Iglehart, J. Dirk, Richardson, Andrea, Come, Steven E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669373/ https://www.ncbi.nlm.nih.gov/pubmed/23741308 http://dx.doi.org/10.1371/journal.pone.0064225 |
Ejemplares similares
-
How drug resistance takes shape
por: Jeselsohn, Rinath, et al.
Publicado: (2016) -
ESR1 fusions and therapeutic resistance in metastatic breast cancer
por: Nagy, Zsuzsanna, et al.
Publicado: (2023) -
Corrigendum: ESR1 fusions and therapeutic resistance in metastatic breast cancer
por: Nagy, Zsuzsanna, et al.
Publicado: (2023) -
Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer
por: Kuang, Yanan, et al.
Publicado: (2018) -
Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status
por: Downton, Teesha, et al.
Publicado: (2022)